Rohto Pharmaceutical Co.,Ltd. (4527.T)
JPY 2680.5
(0.11%)
JPY 2680.5
(0.11%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 270.84 Billion | 238.66 Billion | 199.64 Billion | 181.05 Billion | 188.37 Billion | 183.67 Billion |
| Cost of Revenue | 115.9 Billion | 101.24 Billion | 83.15 Billion | 74.32 Billion | 74.13 Billion | 74.04 Billion |
| Gross Profit | 154.93 Billion | 137.42 Billion | 116.48 Billion | 106.72 Billion | 114.24 Billion | 109.62 Billion |
| Operating Expenses | 117.23 Billion | 103.45 Billion | 87.13 Billion | 83.73 Billion | 91.67 Billion | 88.8 Billion |
| Selling, General and Administrative Expenses | 101.3 Billion | 46.46 Billion | 38.11 Billion | 40.52 Billion | 47.92 Billion | 47.67 Billion |
| Research and Development Expenses | 11.79 Billion | 11.06 Billion | 8.74 Billion | 7.9 Billion | 7.05 Billion | 6.83 Billion |
| Other Expenses | 4.13 Billion | -63 Million | 246 Million | 260 Million | -33 Million | -40 Million |
| Cost and Expenses | 230.79 Billion | 204.7 Billion | 170.29 Billion | 158.05 Billion | 165.81 Billion | 162.85 Billion |
| Operating Income | 40.04 Billion | 33.95 Billion | 29.34 Billion | 22.99 Billion | 23.08 Billion | 20.81 Billion |
| Interest Expense | 196 Million | 247 Million | 248 Million | 145 Million | 125 Million | 148 Million |
| Income Tax Expense | 10.12 Billion | 7.86 Billion | 6.8 Billion | 6.23 Billion | 6.44 Billion | 6.48 Billion |
| Earnings before Tax | 41.51 Billion | 34.29 Billion | 27.95 Billion | 23 Billion | 21.73 Billion | 16.3 Billion |
| Net Income | 30.93 Billion | 26.37 Billion | 21.12 Billion | 16.74 Billion | 15.41 Billion | 9.79 Billion |
| Earnings Per Share Basic | 135.60 | 115.62 | 92.61 | 73.39 | 67.56 | 43.00 |
| Earnings Per Share Diluted | 135.21 | 115.29 | 92.34 | 73.18 | 67.36 | 42.83 |
| Weighted Average Shares Outstanding | 228.13 Million | 228.13 Million | 228.14 Million | 228.14 Million | 228.07 Million | 227.91 Million |
| Weighted Average Shares Outstanding (Diluted) | 228.79 Million | 228.79 Million | 228.79 Million | 228.8 Million | 228.78 Million | 228.78 Million |
| Gross Margin | 0.57 | 0.58 | 0.58 | 0.59 | 0.61 | 0.60 |
| EBIT Margin | 0.18 | 0.18 | 0.19 | 0.18 | 0.16 | 0.14 |
| Profit Margin | 0.11 | 0.11 | 0.11 | 0.09 | 0.08 | 0.05 |
| EBITDA | 48.85 Billion | 41.33 Billion | 35.81 Billion | 28.61 Billion | 29.81 Billion | 27.21 Billion |
| Earnings Before Tax Margin | 0.15 | 0.14 | 0.15 | 0.13 | 0.12 | 0.11 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 68.35 Billion | 270.84 Billion | 62.4 Billion | 73.29 Billion | 66.69 Billion | 61.17 Billion |
| Cost of Revenue | 29.28 Billion | 115.9 Billion | 26.41 Billion | 29.93 Billion | 28.51 Billion | 25.39 Billion |
| Gross Profit | 39.07 Billion | 154.93 Billion | 35.98 Billion | 43.36 Billion | 38.18 Billion | 35.77 Billion |
| Operating Expenses | 27.28 Billion | 114.76 Billion | 30.62 Billion | 29.06 Billion | 28.51 Billion | 24.47 Billion |
| Selling, General and Administrative Expenses | 27.45 Billion | - | 27.98 Billion | 26.31 Billion | 25.5 Billion | 24.23 Billion |
| Research and Development Expenses | 3.62 Billion | - | 4.97 Billion | 2.75 Billion | 3.15 Billion | 2.5 Billion |
| Other Expenses | -164 Million | 505 Million | -190 Million | 263 Million | 252 Million | 180 Million |
| Cost and Expenses | 56.56 Billion | 230.67 Billion | 64.89 Billion | 58.99 Billion | 57.02 Billion | 49.87 Billion |
| Operating Income | 11.79 Billion | 40.16 Billion | 5.36 Billion | 14.29 Billion | 9.67 Billion | 11.29 Billion |
| Interest Expense | 65 Million | 196 Million | 53 Million | 71 Million | 63 Million | 46 Million |
| Income Tax Expense | 3.6 Billion | 10.12 Billion | 168 Million | 4.32 Billion | 2.72 Billion | 2.99 Billion |
| Earnings before Tax | 12.09 Billion | 41.51 Billion | 4.76 Billion | 14.02 Billion | 10.3 Billion | 12.24 Billion |
| Net Income | 8.48 Billion | 30.93 Billion | 4.77 Billion | 9.56 Billion | 7.5 Billion | 9.09 Billion |
| Earnings Per Share Basic | 37.18 | - | 20.78 | 41.92 | 32.89 | 39.84 |
| Earnings Per Share Diluted | 37.08 | - | 20.72 | 41.80 | 32.80 | 39.73 |
| Weighted Average Shares Outstanding | 228.74 Million | 228.13 Million | 228.11 Million | 228.13 Million | 228.13 Million | 228.13 Million |
| Weighted Average Shares Outstanding (Diluted) | 228.74 Million | 228.79 Million | 228.77 Million | 228.79 Million | 228.79 Million | 228.79 Million |
| Gross Margin | 0.57 | 0.57 | 0.58 | 0.59 | 0.57 | 0.58 |
| EBIT Margin | 0.20 | - | 0.11 | 0.22 | 0.16 | 0.20 |
| Profit Margin | 0.12 | 0.11 | 0.08 | 0.13 | 0.11 | 0.15 |
| EBITDA | 13.79 Billion | - | 7.16 Billion | 16.48 Billion | 10.77 Billion | 12.11 Billion |
| Earnings Before Tax Margin | 0.17 | 0.15 | 0.09 | 0.20 | 0.15 | 0.18 |
BDRFF
BTCTW
SPTRSHI
002409
605011
002902